Blog

Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients

Photo taken from Sara Elena Rebuzzi/LinkedIn

Jul 1, 2024, 17:38

Sara Elena Rebuzzi: Study protocol of the ongoing study on the first-line therapy in mRCC patients

Sara Elena Rebuzzi, Medical Oncologis at The Hospital of San Paolo, made the following post on LinkedIn:

“Finally published the study protocol of the ongoing prospective/retrospective study on the first-line therapy in mRCC patients!! 520 patients enrolled, but the number is progressively increasing!!

DOI: 10.1186/s12885-024-12319-1.”

Source: Sara Elena Rebuzzi/LinkedIn
.

cancer cancer treatment clinical study first-line therapy Hospital of San Paolo medical oncologist metastatic renal cell carcinoma mRCC OncoDaily Oncology oncology research prospective study Research retrospective study Sara Elena Rebuzzi study protocol

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage